EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance of Quantitative PCR to Distinguish Pneumocystis jirovecii Pneumonia From Colonisation in Immunocompromised Patients

Sara Cederwall iD, Erik Ottander, David Björkhem, Karl Oldberg, Lisa I Påhlman

Mycoses · 2025

DOI: 10.1111/myc.70120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, 2025. Verfasst von Sara Cederwall und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Pneumocystis carinii, Pneumonia, Pneumocystis, Immunocompromised Host, Real-Time Polymerase Chain Reaction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Swedish Research Council, Alfred Österlund Foundation, Swedish Heart and Lung foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pneumocystis jirovecii pneumonia (PCP) is a severe opportunistic infection affecting immunocompromised patients. Quantitative polymerase chain reaction (qPCR) is widely used for the detection of P. jirovecii in respiratory samples. However, the diagnosis of PCP remains challenging and the high prevalence of P. jirovecii airway colonisation complicates the interpretation of positive results. The aim of this study was to assess the utility of P. jirovecii PCR Quantification Cycle (Cq) values in differentiating between PCP and colonisation in PCR‐positive respiratory samples from immunocompromised patients.

Methods

Adult patients with P. jirovecii detected by qPCR in respiratory samples (bronchoalveolar lavage (BAL), sputum and oral wash) collected between 2017 and 2023 were retrospectively enrolled in the study. Patients were classified as having PCP or P. jirovecii colonisation and Cq values were compared between the groups. Receiver‐operating characteristics (ROC) curve analyses were used to assess the performance of Cq values to distinguish between PCP and colonisation, and to establish Cq cut‐off values for the different sample types.

Result

Of 520 included participants, 247 patients (47.5%) were classified as PCP and 273 (52.5%) as colonised. The median Cq value was significantly lower in the PCP group compared to colonised patients in BAL (33.0 vs. 36.6, p < 0.001) and sputum (33.4 vs. 36.0, p < 0.0001), yielding a ROC area under the curve of 0.75 and 0.73, respectively. Cq levels for oral wash did not differ between PCP and colonisation and lacked discriminatory power with a ROC AUC of 0.45. A Cq cut‐off level at 31 for BAL and sputum could predict PCP with a positive predictive value of > 85% while Cq < 38 provided a negative predictive value of 89% for BAL and 73% for sputum.

Conclusion

Different Cq cut‐off values in BAL and sputum may support discrimination between PCP and colonisation and assist physicians in their clinical management of PCP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumocystis cariniiPneumonia, PneumocystisImmunocompromised HostReal-Time Polymerase Chain ReactionHumansMaleFemaleRetrospective StudiesMiddle AgedAgedSputumBronchoalveolar Lavage FluidAdultROC CurveSensitivity and SpecificityAged, 80 and over

Stichwörter der Autor:innen

pneumocystis jiroveciicolonisationdiagnosticspneumoniaquantitative PCR

Autor:innen und Institutionen

  • Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University, Lund, Sweden.
  • Division of Infectious Diseases, Skåne University Hospital, Lund, Sweden.
  • Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden.
  • Clinical Microbiology, Office for Medical Services, Region Skåne, Lund, Sweden.

ORCID-Profile: Sara Cederwall

Förderung

  • The Swedish Research Council
  • Alfred Österlund Foundation
  • Swedish Heart and Lung foundation
  • Swedish Government Funds for Clinical Research (ALF, grant 40204),
  • The medical faculty at Lund University and Region Skåne (WCMM Lund)
  • The Knut and Alice Wallenberg Foundation
  • Vetenskapsrådet
  • Knut och Alice Wallenbergs Stiftelse

Zitieren

APA

Cederwall, S., Ottander, E., Björkhem, D., Oldberg, K., & Påhlman, L. I. (2025). Performance of Quantitative PCR to Distinguish Pneumocystis jirovecii Pneumonia From Colonisation in Immunocompromised Patients. Mycoses. https://doi.org/10.1111/myc.70120

Vancouver

Cederwall S, Ottander E, Björkhem D, Oldberg K, Påhlman LI. Performance of Quantitative PCR to Distinguish Pneumocystis jirovecii Pneumonia From Colonisation in Immunocompromised Patients. Mycoses. 2025. doi:10.1111/myc.70120

BibTeX
@article{Cederwall2025,
  author = {Cederwall, Sara and Ottander, Erik and Björkhem, David and Oldberg, Karl and Påhlman, Lisa I},
  title = {Performance of Quantitative PCR to Distinguish Pneumocystis jirovecii Pneumonia From Colonisation in Immunocompromised Patients},
  journal = {Mycoses},
  year = {2025},
  doi = {10.1111/myc.70120}
}
Kostenlos starten →